NOVN.CH

96.28

+0.18%↑

LONN.CH

543

+0.7%↑

BANB.CH

67.25

+0.75%↑

NOVN.CH

96.28

+0.18%↑

LONN.CH

543

+0.7%↑

BANB.CH

67.25

+0.75%↑

NOVN.CH

96.28

+0.18%↑

LONN.CH

543

+0.7%↑

BANB.CH

67.25

+0.75%↑

NOVN.CH

96.28

+0.18%↑

LONN.CH

543

+0.7%↑

BANB.CH

67.25

+0.75%↑

NOVN.CH

96.28

+0.18%↑

LONN.CH

543

+0.7%↑

BANB.CH

67.25

+0.75%↑

Search

Roche Holding AG

Open

SectorHealthcare

258 0.08

Overview

Share price change

24h

Current

Min

252.8

Max

258.6

Key metrics

By Trading Economics

Income

5.8B

7.8B

Sales

297M

31B

P/E

Sector Avg

23.333

34.393

Dividend yield

3.62

Profit margin

25.31

Employees

103,249

EBITDA

6B

Dividends

By Dow Jones

Dividend yield

Sector Avg

3.62%

2.54%

Market Stats

By TradingEconomics

Market Cap

-589M

205B

Previous open

257.92

Previous close

258

News Sentiment

By Acuity

59%

41%

319 / 374 Healthcare

Roche Holding AG Chart

Past performance is not a reliable indicator of future results.

Related News

24 Jul 2025, 15:09 UTC

Earnings

Roche Weighs Selling Drugs Directly to Patients in Bid to Lower U.S. Prices -- Update

24 Jul 2025, 05:36 UTC

Earnings

Roche Backs 2025 Views After Strong Sales of Key Drugs

11 Jun 2025, 08:25 UTC

Acquisitions, Mergers, Takeovers

EQT, Sanofi Co-Led $135 Million Funding Round for Spanish Biotech Company SpliceBio

12 May 2025, 02:16 UTC

Major Market Movers

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

24 Apr 2025, 07:30 UTC

Earnings

Roche Sales Gain on Boost From Key Drugs Amid U.S. Production Push -- Update

24 Apr 2025, 05:31 UTC

Earnings

Roche Sales Rise Boosted By Key Drugs

8 Aug 2025, 10:51 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Novartis's Midterm Prospects Look Better Than Roche's -- Market Talk

8 Aug 2025, 07:39 UTC

Market Talk
Earnings

Roche Could Reach Peak Earnings Growth This Year -- Market Talk

5 Aug 2025, 10:40 UTC

Market Talk

Roche, Novartis Face Limited Tariff Headwinds for Now -- Market Talk

24 Jul 2025, 06:52 UTC

Market Talk
Earnings

Roche Looks Confident in a Tricky Environment -- Market Talk

24 Jul 2025, 05:05 UTC

Earnings

Roche Backs 2025 View

24 Jul 2025, 05:05 UTC

Earnings

Correct: Roche 1H Diagnostics Sales Down 3%, Reported

24 Jul 2025, 05:04 UTC

Earnings

Correct: Roche 1H Sales Rose 4% On Year , Reported

24 Jul 2025, 05:04 UTC

Earnings

Roche 1H Net Pft Was Seen at CHF8.4B

24 Jul 2025, 05:04 UTC

Earnings

Roche 1H Net Pft CHF7.8B

24 Jul 2025, 05:03 UTC

Earnings

Roche 1H Oper Pft CHF12.0B

24 Jul 2025, 05:03 UTC

Earnings

Roche 1H Diagnostics Sales Down 3% at Constant Currency

24 Jul 2025, 05:03 UTC

Earnings

Roche 1H Sales Rose 4% On Year at Constant Currency

24 Jul 2025, 05:02 UTC

Earnings

Roche 1H Sales CHF30.9B , In Line With Analyst Views

21 Jul 2025, 06:44 UTC

Market Talk

Roche Drug Candidate Disappoints in Lung Disease Trials -- Market Talk

16 Jun 2025, 08:55 UTC

Hot Stocks

Stocks to Watch: Victoria's Secret, Renault, U.S. Steel, Sarepta -- WSJ

3 Jun 2025, 07:51 UTC

Market Talk

Roche Unlikely to Get Revenue Boost From Tecentriq Combination With Lurbinectedin -- Market Talk

21 May 2025, 07:20 UTC

Market Talk

Roche Lymphoma Drug Columvi Dealt Setback by FDA Committee -- Market Talk

2 May 2025, 06:25 UTC

Market Talk
Earnings

Roche Shows Pipeline Progress But Near-Term Risks Remain -- Market Talk

24 Apr 2025, 09:39 UTC

Market Talk
Earnings

Roche's Pipeline in Focus After Solid Results -- Market Talk

24 Apr 2025, 09:24 UTC

Market Talk
Earnings

Roche's Reiterated Outlook Looks Reassuring -- Market Talk

24 Apr 2025, 09:18 UTC

Market Talk
Earnings

Roche's Results Are Solid -- Market Talk

24 Apr 2025, 05:16 UTC

Top News

Roche Sales Rise, Boosted By Key Drugs

22 Apr 2025, 10:51 UTC

Top News

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs -- WSJ

15 Apr 2025, 09:55 UTC

Market Talk

U.S Pharma Import Probe Clouds Clarity for EU Companies -- Market Talk

Peer Comparison

Price change

Roche Holding AG Forecast

Sentiment

By Acuity

319 / 374 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. It has strategic discovery collaboration with Flare Therapeutics Inc. proteomic and mass spectrometry platform and expertise to discover novel small molecules aimed at transcription factor targets in oncology. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.